Evidence map›Paper›PMID 39624521›Full record

ArticleCureus2024

Genetic Testing and Analysis in Breast Cancer Patients in Greece.

Ioannis Rellias, Drakoulis Yannoukakos, Florentia Fostira, Paraskevi Apostolou, Andreas Pampanos, Dimitrios Loutradis, George Daskalakis, Constantine Dimitrakakis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ioannis RelliasFirst Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, GRC.
Drakoulis YannoukakosHuman Molecular Genetics Laboratory INRASTES (Nuclear & Radiological Sciences and Technology, Energy & Safety), National Centre for Scientific Research Demokritos, Athens, GRC.
Florentia FostiraHuman Molecular Genetics Laboratory INRASTES (Nuclear & Radiological Sciences and Technology, Energy & Safety), National Centre for Scientific Research Demokritos, Athens, GRC.
Paraskevi ApostolouHuman Molecular Genetics Laboratory INRASTES (Nuclear & Radiological Sciences and Technology, Energy & Safety), National Centre for Scientific Research Demokritos, Athens, GRC.
Andreas PampanosGenetics, Alexandra General Hospital, Athens, GRC.
Dimitrios LoutradisFirst Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, GRC.
George DaskalakisFirst Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, GRC.
Constantine DimitrakakisFirst Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Genetic testing for inherited breast cancer predisposing pathogenic variants (PVs) inform treatment choices and guide clinical management strategies in breast cancer patients. Methods The study enrolled 146 patients, sourced from the Breast Unit database of the First Department of Obstetrics and Gynecology at the University of Athens, Alexandra Hospital. Blood samples were collected for genetic testing, utilizing a detailed 94-cancer gene panel. The results were then descriptively correlated with the clinicopathological data of the patients. Results In this study, 17 PVs were identified across several genes,

Indexed as

brca1brca2breast cancerbrip1chek2family historygeneticsgermline pathogenic variantsmsh2tp53

Identifiers

PMID39624521
PMCPMC11611303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.